Brain tumor vaccine links mutation targeting to eight-year survival gains

Дата публикации: 06-07-2026 16:00:09

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions have published encouraging long-term results from a clinical trial involving a vaccine that activates the immune system against a common genetic mutation in these tumors.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	This virus therapy supercharges the immune system against brain cancer	0	5.39	20-03-2026
2	First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients	7	8	10-07-2026
3	Trial of vaccine for brain cancer misses primary endpoint	0	9.35	07-10-2026
4	This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice	0	13.68	17-07-2026
5	Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors	2	8	20-07-2026
6	A common vitamin could help fight one of the deadliest brain cancers	0	7.79	22-06-2026
7	Германия — Охота на мутанта	0	7	09-07-2026
8	Vaccine may ‘intercept’ pancreatic cancer before it starts	0	13.27	16-07-2026
9	Electric fields offer new hope against aggressive brain cancer	0	7.9	13-08-2026
10	حقنة جديدة تبعث الأمل.. علاج واعد يقضي على أورام السرطان	7	8	01-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 7. Информативность: 8. Источник: medicalxpress.com.